Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Primary hemostasis exploration].

A Stepanian1, C Biron-Andréani

  • 1Laboratoire central d'hématologie, Hôpital Saint-éloi, Montpellier, France.

Annales De Biologie Clinique
|November 20, 2001
PubMed
Summary

This review explores the most effective tests for diagnosing primary hemostasis disorders in routine labs. It emphasizes the importance of pre-analytical steps like proper blood collection and patient history. The authors highlight platelet count, bleeding time, and occlusion time as key diagnostics. They also discuss the role of von Willebrand disease and platelet function disorders in hemostasis. The review suggests that current methods have limitations in capturing endothelial cell involvement. Future research may focus on integrating new markers like adhesion proteins into standard testing protocols.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thrombosis in the perforasome in idiopathic purpura fulminans with anti-protein S antibodies: Anatomical and clinical evidence to improve management.

Clinical hemorheology and microcirculation·2024
Same author

Cross-reactivity of human anti-FVIII antibodies to porcine rFVIII: French field study to validate the modified Nijmegen method.

International journal of laboratory hematology·2024
Same author

Post-viral idiopathic purpura fulminans is associated with inherited thrombophilia and anti-cardiolipin antibodies.

Frontiers in pediatrics·2023
Same author

Imbalance between procoagulant factors and natural coagulation inhibitors contributes to hypercoagulability in the critically ill COVID-19 patient: clinical implications.

European review for medical and pharmacological sciences·2020
Same author

Roux-en-Y gastric bypass, but not sleeve gastrectomy, decreases plasma PCSK9 levels in morbidly obese patients.

Diabetes & metabolism·2020
Same author

[Thromboembolic disease in pediatric oncology].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2018

Area of Science:

  • Clinical hematology diagnostics
  • Thrombosis and hemostasis research
  • Medical laboratory science

Background:

Primary hemostasis diagnostics rely on multiple specialized tests, but few are routinely used for initial diagnosis. Prior research has shown that pre-analytical factors strongly influence results. This gap motivated the need to clarify which assays are most useful in routine settings. It was already known that platelet count and bleeding time are foundational metrics. However, no prior work had resolved how to integrate newer tests like prothrombin consumption. The role of endothelial cells remains unclear in standard practice. This uncertainty limits the ability to diagnose disorders like von Willebrand disease efficiently. That uncertainty drove efforts to synthesize current diagnostic approaches.

Purpose Of The Study:

This review aims to clarify the most practical diagnostic tools for primary hemostasis in routine labs. It addresses the challenge of selecting tests that balance simplicity and reliability. The study focuses on thrombocytopenia, von Willebrand disease, and platelet function disorders. It was already known that diagnostic accuracy depends on proper sample collection. This paper seeks to highlight how pre-analytical steps affect outcomes. The authors propose that occlusion time and platelet count are essential for initial screening. They also aim to outline the limitations of current methods. By synthesizing existing literature, the study hopes to guide diagnostic workflows.

Keywords:
Hemostasis testingPlatelet diagnosticsClinical laboratory methodsThrombosis diagnostics

Frequently Asked Questions

Platelet count, bleeding time, and occlusion time are proposed as foundational diagnostics.

Von Willebrand disease detection involves measuring von Willebrand factor levels.

The authors propose that sample collection and clinical history strongly influence diagnostic accuracy.

The prothrombin consumption test is proposed as a tool for identifying clotting deficiencies.

Occlusion time is proposed as a more reliable alternative to bleeding time in some cases.

Related Experiment Videos

Main Methods:

The review approach includes a structured analysis of hemostasis tests used in clinical labs. It organizes findings into four thematic sections for clarity. The first section covers global hemostasis metrics like platelet count and bleeding time. The second section focuses on diagnostic tools for specific disorders. The third section discusses limitations of current methods. The fourth section explores future directions, including endothelial cell involvement. The authors use a narrative synthesis of peer-reviewed literature. They emphasize the importance of pre-analytical variables. The review does not include original experiments or statistical modeling.

Main Results:

Platelet count remains the most widely used diagnostic marker in primary hemostasis. Bleeding time and occlusion time are proposed as complementary tools. Prothrombin consumption test is highlighted for its role in identifying clotting deficiencies. Thrombocytopenia diagnosis relies heavily on platelet count and morphology. Von Willebrand disease detection involves measuring von Willebrand factor levels. Platelet function disorders require specialized assays like flow cytometry. The review suggests that endothelial cell function is underexplored in standard diagnostics. Future directions may involve integrating adhesion protein measurements into routine testing.

Conclusions:

The authors propose that pre-analytical steps are crucial for accurate hemostasis testing. They suggest that platelet count and bleeding time remain foundational diagnostics. The review highlights the need for better integration of endothelial cell markers. They propose that occlusion time is a reliable alternative to bleeding time. The authors suggest that von Willebrand disease detection requires multiple assays. They propose that thrombocytopenia diagnosis benefits from a combination of tests. The review suggests that current methods have limitations in capturing adhesion protein roles. The authors conclude that future research should focus on improving diagnostic specificity.

The authors suggest integrating endothelial cell markers and adhesion proteins into routine testing.